Yates J. Tuberous sclerosis. Eur J Hum Genet. 2006;14:1065-73 pubmed
..There is now the exciting possibility of drug therapy for some of the manifestations of the disease. ..
Yates J, Sepp T, Matharu B, Khan J, Thurlby D, Shahid H, et al. Complement C3 variant and the risk of age-related macular degeneration. N Engl J Med. 2007;357:553-61 pubmed
..Complement C3 is important in the pathogenesis of age-related macular degeneration. This finding further underscores the influence of the complement pathway in the pathogenesis of this disease. ..
Yates J, MacLean C, Higgins J, Humphrey A, le Maréchal K, Clifford M, et al. The Tuberous Sclerosis 2000 Study: presentation, initial assessments and implications for diagnosis and management. Arch Dis Child. 2011;96:1020-5 pubmed publisher